drugset / Trial / NCT00003428
Hormone Therapy in Treating Women With Breast Cancer
Phase 2
Completed
114 enrolled
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI) · collab
RandomizedTreatment
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using arzoxifene hydrochloride may fight breast cancer by blocking the use of estrogen by the tumor cells. PURPOSE: This randomized phase II trial is comparing two different doses of arzoxifene hydrochloride to see how well it works in treating women with advanced or metastatic breast cancer.
Timeline
- Start
- 1998-05
- Primary completion
- 2001-06
- Completion
- 2001-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | arzoxifene | Other / unclassified | — | Oral |